<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17158" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acute Mountain Sickness</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Prince</surname>
            <given-names>Timothy S.</given-names>
          </name>
          <aff>University of Kentucky</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thurman</surname>
            <given-names>Jeff</given-names>
          </name>
          <aff>University of Louisville/Norton Healthcare</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huebner</surname>
            <given-names>Kermit</given-names>
          </name>
          <aff>Wright State University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Timothy Prince declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jeff Thurman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kermit Huebner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17158.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>At higher altitudes, the decreased partial pressure of oxygen can cause several pathological presentations, including high altitude pulmonary edema, high altitude cerebral edema, and the more mild, but much more common acute mountain sickness (also referred to as altitude illness or altitude sickness). High altitude pulmonary edema and high altitude cerebral edema are both life-threatening emergencies requiring immediate treatment with prompt descent to lower altitude (or artificial high pressure environment). In contrast, acute mountain sickness can be prevented or managed with oral medication, and does not typically require prompt descent or oxygen supplementation. This activity reviews the evaluation and management of patients with acute mountain sickness and provides recommendations to preventing the condition. This activity highlights the role of the interprofessional team in caring for and counseling patients at risk for acute mountain sickness.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe how to prevent altitude sickness by modifying the rate of ascent.</p></list-item><list-item><p>Describe how to use acetazolamide for both prophylaxis and treatment of acute mountain sickness.</p></list-item><list-item><p>Describe the prognosis for patients with acute mountain sickness.</p></list-item><list-item><p>Identify interprofessional team strategies to coordinate care to more effectively prevent and treat acute mountain sickness.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17158&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17158">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17158.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>As the number of international, adventure, and wilderness travelers increase,&#x000a0;physicians in all locations and types of practices may be asked to counsel and&#x000a0;provide prophylaxis or self-treatment for a variety of travel-related&#x000a0;illnesses.&#x000a0;At higher altitudes, the decreased partial pressure of oxygen can cause several pathological&#x000a0;presentations, including High Altitude Pulmonary Edema, High Altitude&#x000a0;Cerebral Edema, and the milder, but much more common, Acute Mountain&#x000a0;Sickness (also referred to as Altitude Illness or Altitude Sickness).&#x000a0;High Altitude Pulmonary Edema&#x000a0;and&#x000a0;High Altitude&#x000a0;Cerebral Edema&#x000a0;are both life-threatening emergencies requiring immediate treatment, with a descent to lower altitude (or higher pressure artificial environment) as quickly as can be safely arranged and executed.&#x000a0; In contrast,&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;symptoms can be prevented or managed with oral medication, and&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;does not typically require descent or oxygen supplementation. High altitude environments exist at elevations over 1,500 meters. The higher the altitude, the less the oxygen saturation and risk of hypoxemia.<xref ref-type="bibr" rid="article-17158.r1">[1]</xref></p>
      </sec>
      <sec id="article-17158.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Acute Mountain&#x000a0;Sickness&#x000a0;is caused by the body&#x02019;s reaction to the reduced oxygen&#x000a0;level in respired air and resultant tissue hypoxia.&#x000a0;At baseline metabolic levels, the brain is the most sensitive organ regarding hypoxia and oxygen stress. Thus, the symptoms of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;(discussed below) are mediated by the central nervous system (CNS). In many travelers at altitude, respirations during sleep develop a periodic pattern that may contribute to the development of symptoms.<xref ref-type="bibr" rid="article-17158.r2">[2]</xref><xref ref-type="bibr" rid="article-17158.r3">[3]</xref></p>
      </sec>
      <sec id="article-17158.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;increases with&#x000a0;increasing&#x000a0;altitude.&#x000a0;While&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;is very&#x000a0;uncommon under 2500 m, the percentage&#x000a0;of non-acclimated travelers affected at 3000 m approaches 75%. Any travelers with&#x000a0;prior episodes of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;are at greater risk than those who have tolerated similar trips in the past.</p>
        <p>Pre-existing diseases can increase&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;risk by magnifying the effects of&#x000a0;the hypoxia. The most common conditions in this category include anemia, with a reduced oxygen-carrying capacity of the blood, and chronic obstructive pulmonary disease, due to the reduced degree of&#x000a0;oxygenation occurring in the lungs.</p>
        <p>Given the suspected severity of&#x000a0;the underlying process, careful pre-trip measures should include: screening to&#x000a0;characterize the severity of the disease, additional treatment of the underlying condition, a lower&#x000a0;threshold altitude to begin prophylaxis to reduce the risk of hypoxia, enhanced preparation for&#x000a0;treatment during the trip, and recommendations to modify the itinerary.<xref ref-type="bibr" rid="article-17158.r4">[4]</xref><xref ref-type="bibr" rid="article-17158.r5">[5]</xref></p>
      </sec>
      <sec id="article-17158.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>As the brain has the highest baseline need for oxygen supply, the symptoms of&#x000a0;Acute Mountain&#x000a0;Sickness are neurologic&#x000a0;(central nervous system CNS). As the generalized hypoxia can affect multiple functions, CNS symptoms are not specific&#x000a0;or localizing.&#x000a0;Lower respiratory rate, typical during&#x000a0;sleep, increases the risk for&#x000a0;Acute Mountain&#x000a0;Sickness,&#x000a0;and symptoms are often first noticed upon awakening. For the majority of people, acclimatization at altitudes over 5600 meters is not possible and prolonged stay at these heights can be associated with respiratory distress.<xref ref-type="bibr" rid="article-17158.r6">[6]</xref></p>
      </sec>
      <sec id="article-17158.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The hallmark of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;is a headache, with other symptoms including nausea, vomiting, loss of&#x000a0;appetite, fatigue/malaise (particularly at rest), sleep disturbance, and dizziness/lightheadedness. &#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;symptoms can&#x000a0;begin after only a few hours and typically present the first day at a given&#x000a0;altitude, resolving after one to three&#x000a0;days, even without treatment, as the body adjusts&#x000a0;physiologically (acclimates) to the lower oxygen levels.</p>
        <p>The presence of facial or extremity edema can be present with or without&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;symptoms and is felt to be a marker for not yet being acclimated to the altitude. Rarely, retinal hemorrhages can occur and affect visual fields.</p>
      </sec>
      <sec id="article-17158.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Acute mountains sickness is a clinical diagnosis based on the presence of a headache, with or without the other typical symptoms, in the appropriate&#x000a0;setting.&#x000a0; There is no specific lab or other testing recommended. Since the symptoms of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;are nonspecific, the presence of&#x000a0;atypical symptoms, such as diarrhea, should trigger an evaluation for other causes. Also, the patient may have increased their alcohol intake while traveling, and this should be considered when evaluating. Finally, the presence of&#x000a0;additional or more severe neurologic symptoms is indicative of&#x000a0;possible High Altitude&#x000a0;Cerebral Edema&#x000a0;and should be treated as a medical emergency.&#x000a0;<xref ref-type="bibr" rid="article-17158.r7">[7]</xref><xref ref-type="bibr" rid="article-17158.r8">[8]</xref></p>
      </sec>
      <sec id="article-17158.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>For a traveler going to an at-risk altitude, the most significant modifiable risk factor is the rate of ascent.&#x000a0;More gradual ascent allows the body&#x02019;s physiological processes to adjust to the reduced partial pressure of oxygen at the new altitude. Planning the trip to allow for such acclimation is the most&#x000a0;natural method of prevention and, when possible within the parameters of the patient&#x02019;s overall travel plans, is preferred to eliminate the risk of side-effects&#x000a0;from pharmacologic management. This method will also reduce the risk of worsening or triggering any oxygen-sensitive underlying conditions which are present (discussed above). Because of the change in respiratory pattern during sleep, the altitude at which the traveler sleeps is more important for AMS risk than the maximal altitude reached during the day. The optimal rate of ascent (sleep altitude) should be no more than 500 m per day at levels greater than 2500 m.&#x000a0;Also, allowing at least one day to acclimate around 2500 m before further ascent, and then again for every additional 1000 m ascent, will reduce risk.&#x000a0;Avoiding exercise and alcohol for the first 48 hours until acclimated may also minimize the risk of symptoms. If&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;does occur, further ascent is not advisable until acclimated. Having the patient descend is also curative when symptoms are persistent and should be considered when possible in the rare cases when symptoms are progressive despite treatment.<xref ref-type="bibr" rid="article-17158.r9">[9]</xref><xref ref-type="bibr" rid="article-17158.r10">[10]</xref><xref ref-type="bibr" rid="article-17158.r11">[11]</xref> Regarding pharmacologic measures, acetazolamide is currently used most commonly for both prophylaxis and treatment of&#x000a0;Acute Mountain&#x000a0;Sickness. Prophylaxis is used if going to greater than 9000 feet without acclimatization and can be considered at somewhat lower levels if the traveler has had&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;previously or has other risk factors. Acetazolamide decreases the pH level of the blood, which then causes an increased respiratory rate. It is well tolerated in general,&#x000a0;but patients should be advised that use can cause tingling of the digits and even lips.&#x000a0;</p>
        <p>Dexamethasone use is less frequent for&#x000a0;Acute Mountain&#x000a0;Sickness, and it is used primarily as a treatment, though occasionally may be considered for prophylaxis in certain settings. Ibuprofen may also be effective as a non-prescription option, and some travelers may be more comfortable using ibuprofen since they are familiar with it. All three treatments may cause gastrointestinal (GI) symptoms, which may overlap with those seen in some instances of&#x000a0;Acute Mountain&#x000a0;Sickness.&#x000a0;Assuming the medications are tolerated, use should continue until the traveler has at least one to two days at the highest altitude reached to acclimate.<xref ref-type="bibr" rid="article-17158.r12">[12]</xref></p>
      </sec>
      <sec id="article-17158.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Hypothermia</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ischemic stroke</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Meningitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Migraine headache</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric aseptic meningitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric bacterial meningitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric dehydration</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric headache</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Reye syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sinusitis imaging</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17158.s10" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>Ataxia</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
          <list-item>
            <p>Brain herniation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17158.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Also, while accessing the potential risk of altitude to the traveler, it is important to note that the stress of reduced oxygen&#x000a0;levels may worsen other medical conditions such as angina, congestive heart&#x000a0;failure, and sickle cell (trait or disease), all independent of&#x000a0;Acute Mountain&#x000a0;Sickness&#x000a0;symptoms.&#x000a0;</p>
      </sec>
      <sec id="article-17158.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of acute mountain sickness is an interprofessional. While the physician may treat the acute symptoms, the key is to prevent the symptoms&#x000a0;in the first place. The sports nurse,&#x000a0;respiratory therapist, pulmonologist and physical therapist should educate the patient on the importance of staged&#x000a0;ascents. If ever the individual develops symptoms at a certain height, the key is to go back down immediately. Anyone with symptoms following a mountain climb should seek immediate medical assistance, because the cerebral symptoms can quickly take a negative downturn. Finally, the pharmacist should educate the patient on routine prophylaxis with acetazolamide and discontinue smoking when climbing mountains. Today, there are portable oxygen sensors that one can wear which will sense the oxygen concentration in the body.&#x000a0;<xref ref-type="bibr" rid="article-17158.r13">[13]</xref><xref ref-type="bibr" rid="article-17158.r14">[14]</xref> (Level V)</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>For most patients the outcome after suffering from acute mountain sickness is good; however, complete recovery may take time. Many climbers will develop symptoms of acute mountain sickness on an ascent. However, sometimes the symptoms may be delayed for 24-48 hours. One can reduce the intensity of symptoms by descending slightly and then resuming climbing. Complete resolution of symptoms can take 2-5 days, but if one continues to climb in the presence of symptoms, one can develop confusion, disorientation and lapse into a coma. Brain herniation has been reported and often the course is fatal. Those who survive may have memory and gait deficits that persist for months. <xref ref-type="bibr" rid="article-17158.r15">[15]</xref><xref ref-type="bibr" rid="article-17158.r16">[16]</xref>(Level V)</p>
      </sec>
      <sec id="article-17158.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17158&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17158">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/acute-mountain-sickness-altitude-illness-altitude-sickness/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17158">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17158/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17158">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17158.s14">
        <title>References</title>
        <ref id="article-17158.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacey</surname>
                <given-names>JRN</given-names>
              </name>
              <name>
                <surname>Kidel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van der Kaaij</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Brinkman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gilbert-Kawai</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Grocott</surname>
                <given-names>MPW</given-names>
              </name>
              <name>
                <surname>Mythen</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>DS</given-names>
              </name>
              <collab>Xtreme Everest 2 Research Group</collab>
            </person-group>
            <article-title>The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness.</article-title>
            <source>Physiol Rep</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>17</issue>
            <fpage>e13854</fpage>
            <pub-id pub-id-type="pmid">30187693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000e4;rtsch</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of Headache and Relationship to Acute Mountain Sickness at 4559 Meters.</article-title>
            <source>High Alt Med Biol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-328</page-range>
            <pub-id pub-id-type="pmid">30067102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Physiological, hematological and biochemical factors associated with high-altitude headache in young Chinese males following acute exposure at 3700&#x000a0;m.</article-title>
            <source>J Headache Pain</source>
            <year>2018</year>
            <month>Jul</month>
            <day>25</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <pub-id pub-id-type="pmid">30046908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez-Mascu&#x000f1;ano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masuet-Aumatell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morch&#x000f3;n-Ramos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramon</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Relationship of altitude mountain sickness and smoking: a Catalan traveller's cohort study.</article-title>
            <source>BMJ Open</source>
            <year>2017</year>
            <month>Sep</month>
            <day>24</day>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>e017058</fpage>
            <pub-id pub-id-type="pmid">28947454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koirala</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pandit</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Phuyal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zafren</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Yarsagumba Fungus: Health Problems in the Himalayan Gold Rush.</article-title>
            <source>Wilderness Environ Med</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-270</page-range>
            <pub-id pub-id-type="pmid">28716290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masuet-Aumatell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Mascu&#x000f1;ano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santangelo</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ramon-Torrell</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Relationship between Smoking and Acute Mountain Sickness: A Meta-Analysis of Observational Studies.</article-title>
            <source>Biomed Res Int</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>1409656</fpage>
            <pub-id pub-id-type="pmid">29259975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brodmann Maeder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brugger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strapazzon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dal Cappello</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maggiorini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hackett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>B&#x000e4;rtsch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Zafren</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The STAR Data Reporting Guidelines for Clinical High Altitude Research.</article-title>
            <source>High Alt Med Biol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-14</page-range>
            <pub-id pub-id-type="pmid">29596018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luks</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Evaluating the Risks of High Altitude Travel in Chronic Liver Disease Patients.</article-title>
            <source>High Alt Med Biol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>80</fpage>
            <page-range>80-8</page-range>
            <pub-id pub-id-type="pmid">25844541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garlick</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shubkin</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>High-altitude illness in the pediatric population: a review of the literature on prevention and treatment.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>503</fpage>
            <page-range>503-509</page-range>
            <pub-id pub-id-type="pmid">28582330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luks</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McIntosh</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Grissom</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Rodway</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Schoene</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Zafren</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hackett</surname>
                <given-names>PH</given-names>
              </name>
              <collab>Wilderness Medical Society</collab>
            </person-group>
            <article-title>Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update.</article-title>
            <source>Wilderness Environ Med</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>4 Suppl</issue>
            <fpage>S4</fpage>
            <page-range>S4-14</page-range>
            <pub-id pub-id-type="pmid">25498261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luks</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Clinician's corner: What do we know about safe ascent rates at high altitude?</article-title>
            <source>High Alt Med Biol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>147</fpage>
            <page-range>147-52</page-range>
            <pub-id pub-id-type="pmid">22994513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitsteiner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Whitworth</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Nashelsky</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>FPIN's clinical inquiries. Preventing acute mountain sickness.</article-title>
            <source>Am Fam Physician</source>
            <year>2011</year>
            <month>Aug</month>
            <day>15</day>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-400</page-range>
            <pub-id pub-id-type="pmid">21842785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The effects of respiratory inhaled drugs on the prevention of acute mountain sickness.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>32</issue>
            <fpage>e11788</fpage>
            <pub-id pub-id-type="pmid">30095637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macholz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sareban</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing Acute Mountain Sickness.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Apr</month>
            <day>10</day>
            <volume>319</volume>
            <issue>14</issue>
            <fpage>1509</fpage>
            <pub-id pub-id-type="pmid">29634823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Collet</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Locatelli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cornuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kayser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Simel</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Sartori</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Nov</month>
            <day>14</day>
            <volume>318</volume>
            <issue>18</issue>
            <fpage>1810</fpage>
            <page-range>1810-1819</page-range>
            <pub-id pub-id-type="pmid">29136449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17158.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacNutt</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Laursen</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Kedia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neupane</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parajuli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pokharel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sheel</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Acclimatisation in trekkers with and without recent exposure to high altitude.</article-title>
            <source>Eur J Appl Physiol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>112</volume>
            <issue>9</issue>
            <fpage>3287</fpage>
            <page-range>3287-94</page-range>
            <pub-id pub-id-type="pmid">22252248</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
